Residency Listing

Karmanos Cancer Center
4100 John R Road
Detroit, MI 48201
Code: 43285
NMS Code: *543860,543890
Postgraduate Year Two (PGY2)
Oncology Pharmacy
Accreditation Status: Accredited
Residency Program Director: Chin Y Liu, Pharm.D., MS, BCOP
(313) 576-8803
Fax: (313) 576-8811
Director of Pharmacy: Stephen T Smith, M.S., FASHP
(313) 576-8809
Fax: (313) 576-8811
Program Contact: Chin Y Liu, Pharm.D., MS, BCOP
(313) 576-8803
Fax: (313) 576-8811
Residency Information:
Duration/Type: 12 mo. residency
Number of Positions: 1
Application Deadline: 2019-01-15
Estimated Stipend: 47000
Interview Required: Yes
Residency Special Features:   NMS Code: *543860 traditional position, NMS Code 543890 nontraditional position. This PGY2 oncology pharmacy residency is an intensive residency designed to refine the resident's clinical skills and provide the resident with a body of knowledge germane to the management of patients with cancer. Practice areas include solid tumors, malignant hematology, pediatric hematology/oncology, stem cell transplantation, investigational drug service, and ambulatory care. The resident conducts a major research project, presents formal lectures, and participates in the oncology journal club, inservices, and the Hematology/Oncology Pharmacy & Therapeutics Committee.
Fringe Benefits:   The resident receives health insurance, sick leave, paid vacation, and professional travel reimbursement for the ASHP MCM.
Special Requirements for Acceptance:   Pharm.D. degree, ASHP-accredited postgraduate year one (PGY1) pharmacy residency. Eligibility for Michigan licensure.
Training Site Type: Hospital
Owner Affiliate: Private
Model Type(s): Teaching/Tertiary Care
Tax Status: Nonprofit
Professional Staff: 33
Non-Professional Staff: 21
Number of Medical Centers: 7
Total Beds: 122
Average Daily Census: 105
Site Special Features:   The Karmanos Cancer Center (KCC) at the Detroit Medical Center is the patient care enterprise of the Karmanos Cancer Institute (KCI). The KCI is a National Cancer Institute - designated Comprehensive Cancer Center in association with Wayne State University and the Detroit Medical Center (DMC). The KCI is dedicated to state-of-the-art patient care, clinical/basic research, education, and community outreach. We have over 300 open oncology clinical trails, and are members of SWOG, RTOG, GOG, and COG cooperative groups.